Skylands Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-15,195
Closed -$1.22M 187
2017
Q1
$1.22M Sell
15,195
-29,925
-66% -$2.34M 0.17% 109
2016
Q4
$3.21M Buy
45,120
+9,875
+28% +$776K 0.49% 54
2016
Q3
$3.04M Sell
35,245
-400
-1% -$34.9K 0.48% 53
2016
Q2
$3.09M Sell
35,645
-5,300
-13% -$429K 0.51% 51
2016
Q1
$3.07M Sell
40,945
-8,800
-18% -$663K 0.49% 52
2015
Q4
$3.83M Sell
49,745
-14,800
-23% -$1.11M 0.55% 46
2015
Q3
$4.32M Sell
64,545
-2,150
-3% -$158K 0.58% 43
2015
Q2
$4.94M Sell
66,695
-191
-0.3% -$14.6K 0.53% 44
2015
Q1
$5.22M Buy
+66,886
New +$5.07M 0.53% 46

Other funds holding MDT

Skylands Capital's MDT Position: Q2 2017 in Review

Skylands Capital sold out of Medtronic (MDT) in Q2 2017, closing a stake of 15,195 shares — an estimated $1.22M sold.

Skylands Capital first reported a position in MDT in Q1 2015 and held it in 9 quarters. The position peaked at $5.22M in Q1 2015. 1,281 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Skylands Capital reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • Skylands Capital sold 15,195 Medtronic shares in Q2 2017, an estimated $1.22M.
  • Skylands Capital first reported a position in Medtronic in Q1 2015 and held it in 9 quarters.
  • Skylands Capital's Medtronic position peaked at $5.22M in Q1 2015.
  • 1,281 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Skylands Capital's 13F filing for Q2 2017, filed 20 Jul 2017.